Oppenheimer & CO Inc Ocugen, Inc. Transaction History
Oppenheimer & CO Inc
- $6.42 Billion
- Q3 2024
A detailed history of Oppenheimer & CO Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 36,155 shares of OCGN stock, worth $29,285. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,155
Previous 36,155
-0.0%
Holding current value
$29,285
Previous $56,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
124Shares Held
78.3MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$14.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$13.7 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$12.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$5.09 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.99 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $175M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...